Monoclonal CGRP Antibodies for Migraine Prevention - a Nationwide Real Life Study
Clinical trial NCT05281770 · UNKNOWN
Trial details
- NCT number
- NCT05281770
- Sponsor
- Austrian Migraine Registry Collaboration
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-10-01
- Primary completion
- 2025-09-01
- Enrollment
- 1500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.